Cibus, Inc. (NASDAQ:CBUS) Short Interest Down 8.7% in January

Cibus, Inc. (NASDAQ:CBUS) was the target of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 2,110,000 shares, a decrease of 8.7% from the January 15th total of 2,310,000 shares. Based on an average daily trading volume, of 166,400 shares, the days-to-cover ratio is presently 12.7 days. Currently, 10.2% of the company’s stock are sold short.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of CBUS. SG Americas Securities LLC bought a new position in Cibus during the third quarter valued at $33,000. IFP Advisors Inc purchased a new position in shares of Cibus during the 4th quarter valued at $36,000. B. Riley Wealth Advisors Inc. bought a new position in shares of Cibus during the 3rd quarter worth $44,000. Virtu Financial LLC purchased a new stake in Cibus in the 3rd quarter worth about $48,000. Finally, Sei Investments Co. bought a new stake in Cibus in the 4th quarter valued at about $49,000. 33.81% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CBUS has been the topic of a number of analyst reports. HC Wainwright reaffirmed a “buy” rating and set a $25.00 price objective on shares of Cibus in a report on Monday, November 11th. Canaccord Genuity Group cut their price target on shares of Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd.

Cibus Price Performance

Shares of NASDAQ CBUS traded down $0.06 during mid-day trading on Monday, reaching $2.53. 65,134 shares of the company’s stock were exchanged, compared to its average volume of 144,728. The firm has a market capitalization of $66.94 million, a price-to-earnings ratio of -0.11 and a beta of 1.82. The firm has a 50-day moving average price of $2.77 and a two-hundred day moving average price of $4.20. Cibus has a 52 week low of $2.16 and a 52 week high of $23.18.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.